ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 190 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $431,522 | -33.9% | 66,799 | -22.9% | 0.03% | -39.1% |
| Q1 2023 | $653,183 | +274.6% | 86,629 | +403.3% | 0.05% | +253.8% |
| Q4 2022 | $174,358 | -79.6% | 17,212 | -80.1% | 0.01% | -80.0% |
| Q3 2022 | $855,000 | +23.4% | 86,460 | +32.8% | 0.06% | +1.6% |
| Q2 2022 | $693,000 | +4850.0% | 65,109 | +14867.6% | 0.06% | +6300.0% |
| Q1 2021 | $14,000 | – | 435 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |